• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Retrieving Billions in Overpayments by CMS
This article focuses on the relatively young technologies that enable CMS to uncover overbillings, whether they be errors or fraud. The article is based on an interview with Kel Pults, chief clinical officer and vice president of MediQuant. A future article will explain how Medicare Advantage plans are trying to improving data collection and reporting, and how AI helps. Challenges of Investigating Overpayments Undeserved payments are needles lurking in the haystack of 135 million Americans enrolled in Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). But the needles pile up fast. Improper payments f...
Source: EMR and HIPAA - February 17, 2023 Category: Information Technology Authors: Andy Oram Tags: AI/Machine Learning Analytics/Big Data Health IT Company Healthcare IT Regulations Revenue Cycle Management #COVID19 CMS COVID Reimbursement Healthcare AI Healthcare Analytics Kel Pults MAOs Medicare Advantage MediQuant Overp Source Type: blogs

A comprehensive screening for hepatitis B and C as an effective means of cancer prevention and as a prerequisite for elimination of chronic viral hepatitis - Data and comments on a discussion
Dtsch Med Wochenschr. 2023 Feb;148(4):175-182. doi: 10.1055/a-1972-4118. Epub 2023 Feb 7.ABSTRACTSince October 2021 in Germany all people with a statutory health insurance aged 35 and older have the right to be tested once for hepatitis B and C in a general preventative examination, regardless of specific risk-factors. This is a milestone on the way of eliminating these infections and also a great contribution to cancer prevention.In the USA the Centers of Disease Control and Prevention in April 2020 recommended a one-time screening for all adults aged 18 and older in addition to testing people with known risk-factors, bec...
Source: Cancer Control - February 7, 2023 Category: Cancer & Oncology Authors: Ingmar Wolffram Source Type: research

Risk of Guillain-Barr é Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan
CONCLUSIONS AND RELEVANCE: These findings suggest that influenza vaccination did not increase the risk of GBS among adults aged 65 years or older in Taiwan regardless of postvaccination period or underlying characteristics.PMID:36129709 | DOI:10.1001/jamanetworkopen.2022.32571
Source: Cancer Control - September 21, 2022 Category: Cancer & Oncology Authors: Cheng-Chang Yen Kai-Che Wei Wen-Hwa Wang Yu-Tung Huang Yu-Chia Chang Source Type: research

Influenza vaccine and subsequent development of zoster
CONCLUSIONS: There was a slight increase in risk of HZ in people receiving influenza vaccine in the first 1-15 days after vaccination.PMID:36114790 | DOI:10.1111/irv.13055
Source: Herpes - September 17, 2022 Category: Infectious Diseases Authors: Kai-Che Wei Yu-Chia Chang Yu-Tung Huang Source Type: research

Complications and cost estimations in herpes zoster - a retrospective analysis at a Swiss tertiary dermatology clinic
CONCLUSION: In this herpes zoster population at a university hospital, one in three patients was affected by herpes zoster-related complications. Age and cancer were independently associated with a high complication rate, suggesting a need to vaccinate cancer patients. Herpes zoster-related complications and the need for inpatient treatment escalated the costs per case.PMID:34964592 | DOI:10.4414/smw.2021.w30081
Source: Swiss Medical Weekly - December 29, 2021 Category: General Medicine Authors: Leonard D Bongers Alexander Navarini Christoph T Berger Simon M Mueller Source Type: research

Complementary medicine use and flu vaccination - A nationally representative survey of US adults
CONCLUSIONS: Complementary medicine users were equally likely to receive an influenza vaccination compared with non-users. Different complementary therapies showed varied associations with vaccination behavior. Further analyses may be needed to distinguish influencing factors among patients' vaccination behavior.PMID:34419302 | DOI:10.1016/j.vaccine.2021.08.017
Source: Vaccine - August 22, 2021 Category: Allergy & Immunology Authors: Wiebke Kathrin Kohl-Heckl Marleen Schr öter Gustav Dobos Holger Cramer Source Type: research

Role of Annual Influenza Vaccination against Lung Cancer in Type 2 Diabetic Patients from a Population-Based Cohort Study
In this study, we evaluate whether influenza vaccination could reduce the incidence of lung cancer in DM patients. This cohort study included DM patients (≥55 years old) between 1 January 2002 and 31 December 2012 by using the Taiwan Health Insurance Database. Cox proportional hazard regression method was used to compare the relation between the influenza vaccination and lung cancer incidence after adjusting for potential confounders. Sub-group analyses were done according to vaccination status (unvaccinated, total number of vaccinations: 1, 2-3, ≥4) and evaluated the dose-dependent effects on lung cancer events. Among...
Source: Clinical Lung Cancer - August 7, 2021 Category: Cancer & Oncology Authors: Jing-Quan Zheng Cheng-Hsin Lin Chun-Chao Chen Yuan-Feng Lin Chun-Chih Chiu Tsung Yeh Yang Min-Huei Hsu Yu-Ann Fang Wen-Rui Hao Ju-Chi Liu Kang-Yun Lee Source Type: research

Pages: 1  2